MedPath

Protein Supplementation and Neuromuscular Electrical Stimulation in Persons With SCI

Not Applicable
Completed
Conditions
Spinal Cord Injuries
Interventions
Device: NMES
Dietary Supplement: Protein
Registration Number
NCT05249985
Lead Sponsor
Loughborough University
Brief Summary

The aim of this pilot study is to explore how body composition, circulating markers of metabolic health and skin integrity in persons with a spinal cord injury (SCI) are affected by 12 weeks of quadriceps neuromuscular electrical stimulation (NMES) resistance training. The novel element of this study is that one group will be given additional daily protein supplementation in addition to the NMES training (treatment group), whereas the other group will only perform the NMES training (control group). The investigators hypothesise that NMES in combination with protein results in larger improvements in the aforementioned outcomes compared with NMES alone.

Detailed Description

A spinal cord injury (SCI) is a debilitating condition, with paralysis below the lesion level as one of the main hallmarks. As a result of paralysis, together with decreased levels of physical activity and impairment-specific co-morbidities such as autonomic dysfunction, persons with SCI have a markedly reduced muscle mass. Being the major site for glucose disposal, skeletal muscle is key for the maintenance of metabolic health, while it also helps with weight management by contributing to energy expenditure at rest. As such, effective strategies to restore muscle mass in persons with SCI are warranted and can have a significant impact on metabolic health and chronic disease risk in this population.

While resistance training is widely recognised as an effective intervention to increase muscle mass in able-bodied individuals, paralysis in the lower limbs of persons with SCI precludes the use of traditional resistance training in this population. NMES has been developed to overcome this barrier and allows persons with SCI to engage in resistance exercise. Notwithstanding the evidence supporting the use of NMES on its own, combined interventions may further enhance its potential to improve health and physical function. Indeed, in the more widely studied population of older adults, that is also at risk for sarcopenia (loss of skeletal muscle mass and strength), increasing daily protein intake enhances the efficacy of resistance training to increase muscle mass.

The primary objective of this study is to determine the impact of a 12-week intervention of NMES in combination with protein supplementation when compared with NMES alone on fat free mass in the legs. Secondary objectives are to investigate the impact of the intervention on 1) markers of cardiometabolic health, namely glucose tolerance and fasting plasma lipid concentrations, 2) resting metabolic rate, and 3) skin blood flow at the level of the sacrum in response to experimental pressure. Outcomes related to tertiary objectives include perceived quality of life, neuropathic pain, body image, sleep quality and spasms; as well as free-living energy balance, physical activity and feasibility outcomes related to recruitment, adherence and participant' experiences with the intervention. It is hypothesised that NMES in combination with protein results in larger improvements in the aforementioned outcomes compared with NMES alone.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Motor complete spinal cord injury
  • Time since injury injury >1 year
Exclusion Criteria
  • Spinal cord injury below T10 vertebrae
  • Habitual protein intake exceeding 2g / kg body mass / day
  • Having used NMES resistance training once or more per week in the last six months
  • Lactose intolerant
  • Any disease or medication that means the participant should not exercise
  • Participation in a study involving ionising radiation in the previous 12 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
NMES plus protein supplementationNMESParticipants will undergo 12 weeks of neuromuscular electrical stimulation- (NMES) based resistance training on the quadriceps in addition to a daily protein supplement.
NMESNMESParticipants will undergo 12 weeks of neuromuscular electrical stimulation- (NMES) based resistance training on the quadriceps.
NMES plus protein supplementationProteinParticipants will undergo 12 weeks of neuromuscular electrical stimulation- (NMES) based resistance training on the quadriceps in addition to a daily protein supplement.
Primary Outcome Measures
NameTimeMethod
Change in fat massPre-intervention (baseline) and at 1 week post-12 week intervention

Dual x-ray absorptiometry

Change in bone mineral densityPre-intervention (baseline) and at 1 week post-12 week intervention

Dual x-ray absorptiometry

Change in lean soft tissue massPre-intervention (baseline) and at 1 week post-12 week intervention

Dual x-ray absorptiometry

Secondary Outcome Measures
NameTimeMethod
Change in fasting plasma lipid concentrationsPre-intervention (baseline) and at 1 week post-12 week intervention

Resting blood sample

Change in resting metabolic ratePre-intervention (baseline) and at 1 week post-12 week intervention

Expired air analysis

Change in glucose tolerancePre-intervention (baseline) and at 1 week post-12 week intervention

Oral glucose tolerance test

Change in insulin resistancePre-intervention (baseline) and at 1 week post-12 week intervention

Oral glucose tolerance test

Change in fasting circulating C-reactive proteinPre-intervention (baseline) and at 1 week post-12 week intervention

Resting blood sample

Change in sacral skin blood flowPre-intervention (baseline) and at 1 week post-12 week intervention

Doppler flowmetry

Trial Locations

Locations (1)

Loughborough University

🇬🇧

Loughborough, Leicestershire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath